Jiangsu Simcere Pharmaceutical Co., Ltd.

This study aims to see if a new drug called SIM0278 can safely reduce the severity of moderate to severe eczema (atopic dermatitis) in adults. About 184 participants will be randomly assigned to receive one of three different doses of the drug or a placebo for 16 weeks. The main …

This is the first human study of a new injection called SIM0811. Researchers will test increasing doses in 56 healthy Chinese adults to see how safe it is and how the body processes it. They'll also check if it affects blood clotting markers. This early phase helps determine if t…